Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

计划入组 5 人 · 首次发布于 2021 年 10 月 4 日

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

计划入组 12 人 · 首次发布于 2016 年 9 月 5 日

Treatment of TK2 Deficiency With Thymidine and Deoxycytidine

计划入组 23 人 · 首次发布于 2018 年 8 月 21 日

Deoxythymidine/Deoxycytidine

2'-Deoxycytidine

C₉H₁₃N₃O₄

2'-Deoxycytidine 5'-triphosphate

C₉H₁₆N₃O₁₃P₃

Exelixis, Inc.

United States

Inhibikase Therapeutics

United States

Regeneron Pharmaceuticals

United States

Trethera Reports Disease Stabilization in Late-Stage ALS Patient Treated with TRE-515

Trethera Secures $2.7 Million NIH Grant to Evaluate TRE-515 Combination Therapy for KRAS Inhibitor-Resistant Lung Cancer

Trethera Secures $5.3 Million in NIH Funding to Advance First-in-Class dCK Inhibitor TRE-515 Across Cancer and Autoimmune Indications